5-HYDROXYTRYPTOPHAN-SECRETING BRONCHIAL CARCINOID TUMOUR
- 11 November 1961
- journal article
- Published by Elsevier in The Lancet
- Vol. 278 (7211), 1067-1070
- https://doi.org/10.1016/s0140-6736(61)92542-9
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- THE ASSOCIATION OF METASTASIZING BRONCHIAL ADENOMA AND THE FUNCTIONING CARCINOID SYNDROMEAnnals of Internal Medicine, 1961
- FUNCTIONING MALIGNANT BRONCHIAL CARCINOID WITH CUSHING'S SYNDROME AND RECURRENT SINUS ARRESTAnnals of Internal Medicine, 1961
- Metastasizing Bronchial AdenomaPublished by American Medical Association (AMA) ,1960
- Argentaffinoma of the Lung with Carcinoid SyndromeBMJ, 1960
- Metastasizing Bronchial Carcinoid with Hyperserotoninemia and the Carcinoid Syndrome: Report of a CaseMedical Clinics of North America, 1958
- Gastric Mucosal Erosion in the Rat Following Administration of the Serotonin Precursor, 5-HydroxytryptophanExperimental Biology and Medicine, 1957
- CUSHING'S SYNDROME WITH CARCINOMA OF BRONCHUS AND WITH FEATURES SUGGESTING CARCINOID TUMOURThe Lancet, 1957
- PAPER CHROMATOGRAPHY OF URINARY INDOLESThe Lancet, 1955
- Mammalian enterochromaffin cells as the source of serotonin (5‐hydroxytryptamine)The Journal of Pathology and Bacteriology, 1955
- 5-Hydroxytryptamine in a Carcinoid TumourNature, 1953